This website is intended for US healthcare professionals only.

  • Contact Us
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
  • Disease State Information & Resources
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
BioCryst logo
  • BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
  • Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Hereditary angioedema in children: Review and practical perspective for clinical management

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Androgen transition and management of hereditary angioedema long‑term prophylaxis in real life: a single‑center case series

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Clinical Experience with Berotralstat in Patients with Hereditary Angioedema with Normal C1-Esterase Inhibitor: A Commented Case Series

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • The current situation of hereditary angioedema patients in Germany: results of an online survey

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Berotralstat for hereditary angioedema with C1 inhibitor deficiency: a practical guide for clinicians

    View Article

    biocryst

    January 27, 2025
    Hereditary Angioedema (HAE)
  • Definition, acronyms, nomenclature, and classification of angioedema: AAAAI, ACAAI, ACARE, and APAACI DANCE consensus

    View Article

    biocryst

    January 27, 2025
    Hereditary Angioedema (HAE)
  • Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency

    View Article

    biocryst

    January 27, 2025
    Hereditary Angioedema (HAE)
1 2
Next Page
BioCryst logo

2025 BioCryst Pharmaceuticals, Inc.
All Rights Reserved

  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Site Map
Close

You are now leaving biocrystmedical.com.

BioCryst is not responsible for and has no control over the content of linked sites.

Stay on Site Continue

This website is intended for healthcare professionals practicing in the US.

Are you a US healthcare professional? If not, you will be redirected to biocryst.com.

No, I am not a US healthcare professional Yes, I am a US healthcare professional